Clostridium difficile – From Colonization to Infection

H Schaeffler, A Breitrueck - Frontiers in microbiology, 2018 - frontiersin.org
Clostridium difficile is the most frequent cause of nosocomial antibiotic-associated diarrhea.
The incidence of C. difficile infection (CDI) has been rising worldwide with subsequent …

[HTML][HTML] KASL clinical practice guidelines for liver cirrhosis: ascites and related complications

Korean Association for the Study of the … - Clinical and …, 2018 - ncbi.nlm.nih.gov
Aims Ascites is one of the most common complications of liver cirrhosis along with variceal
bleeding and hepatic encephalopathy. It is often the first sign of decompensated cirrhosis …

Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study

T Kawai, K Oda, N Funao, A Nishimura, Y Matsumoto… - Gut, 2018 - gut.bmj.com
Objective Compare efficacy and safety of vonoprazan and lansoprazole for secondary
prevention of low-dose aspirin (LDA)-associated peptic ulcers in a 24-week study and long …

Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux

MD Wilkie, HM Fraser, H Raja - European Archives of Oto-Rhino …, 2018 - Springer
Objectives Management of laryngopharyngeal reflux (LPR) typically comprises alginates
and proton pump inhibitors (PPIs) alone or in combination, yet evidence to support any …

A safety review of proton pump inhibitors to treat acid-related digestive diseases

E Savarino, E Marabotto, P Zentilin… - Expert Opinion on …, 2018 - Taylor & Francis
ABSTRACT Introduction: Proton pump inhibitors (PPIs) have become the first choice medical
treatment of acid-related disease and, as with any pharmacological agent, they have been …

Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet

N Imperatore, R Tortora, A Testa, N Gerbino… - Journal of …, 2018 - Springer
Background Recent research has shown that patients with coeliac disease (CD) are at risk
of developing metabolic syndrome (MS) and hepatic steatosis (HS) after commencing a …

Proton pump inhibitors increase the overall risk of developing bacterial infections in patients with cirrhosis

IB Lázaro-Pacheco, AI Servín-Caamaño… - Arquivos de …, 2018 - SciELO Brasil
ABSTRACT BACKGROUND: Acid suppression has been associated with adverse events;
such as, enteric infections. Proton pump inhibitors (PPI) are frequently prescribed in patients …

[HTML][HTML] Prevalencia de prescripción inapropiada de terapia supresora de ácido en adultos hospitalizados en un hospital general de Bogotá

S Posada Bustos, N De León Fernández… - Revista colombiana de …, 2018 - scielo.org.co
Objetivo: determinar la prevalencia de prescripción de terapia supresora de ácido (TSA)
conformada por los inhibidores de la bomba de protones (IBP) y los antagonistas de los …

Возможные нежелательные побочные реакции ингибиторов протонной помпы у больных пожилого и старческого возраста

ОД Остроумова, АП Переверзев, ГС Краснов - Лечебное дело, 2018 - cyberleninka.ru
Обзор посвящен нежелательным побочным реакциям широко назначаемого в
клинической практике класса препаратов–ингибиторов протонной помпы (ИПП) …

[PDF][PDF] Epidemiology of patients hospitalized with Clostridium difficile infection: A comparative analysis of community-associated and healthcare-associated …

M Salaripour, J Johnstone… - Canadian Journal of …, 2018 - researchgate.net
Objectives: To compare the epidemiology of hospitalized patients with community-acquired
Clostridium difficile infections (CA-CDI) and those with healthcare-associated Clostridium …